BOSTON SCIENTIFIC CORP — Director's Dealing 2022

Feb 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2022-02-15

Reporting Person: Eddy Jodi Euerle (SVP, Chief Info & Digital Off.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-15	Common Stock	M	923.0000	$0.0000	Acquired	22803.0000	Direct
2022-02-15	Common Stock	F	272.0000	$44.0100	Disposed	22531.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-15	Deferred Stock Units	$	M	923.0000	Disposed	2023-02-15	Common Stock (923.0000)	Direct
2022-02-16	Restricted Stock Units	$	A	6223.0000	Acquired	2026-02-16	Common Stock (6223.0000)	Direct
2022-02-16	Stock Option (Right to Buy)	$44.1900	A	17794.0000	Acquired	2032-02-16	Common Stock (17794.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.

F3: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F4: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.

F5: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.